News
BHC
8.62
+0.70%
0.06
Bausch Health Cos. Inc. Stock Rises Thursday, Outperforms Market
Shares of Bausch Health Cos. Inc. Inched 0.51% higher to C$11.79 on Thursday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index rose 0.05% to 21,885.38.
MarketWatch · 22h ago
Bausch + Lomb reports positive study results for Blink NutriTears
Bausch + Lomb reports positive study results for Blink NutriTears. The eyecare company plans to launch the product in the US in early Q3. The study met primary endpoints of change in tear production and participant reports of dry eye symptoms. Bausch and Lomb was spun out of BHC in 2022.
Seeking Alpha · 1d ago
Bausch Health Cos. Inc. Stock Rises Wednesday, Outperforms Market
Shares of Bausch Health Cos. Inc. Inched 0.60% higher to C$11.73 on Wednesday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index fell 0.63% to 21,873.72.
MarketWatch · 1d ago
FDA approves Amneal's generic version of OTC Narcan
FDA approves Amneal Pharmaceuticals’ OTC Naloxone HCl nasal spray, a generic version of the opioid overdose medication OTC Narcan. Narcan is marketed by drugmaker Emergent Biosolutions. Bausch Health filed a patent infringement suit against the company earlier this month.
Seeking Alpha · 2d ago
Bausch Health Cos. Inc. Stock Rises Tuesday, Outperforms Market
Shares of Bausch Health Cos. Inc. Inched 0.69% higher to C$11.66 Tuesday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index rose 0.64% to 22,011.72.
MarketWatch · 2d ago
Bausch Health Is Maintained at Sector Perform by RBC Capital
Dow Jones · 3d ago
Bausch Health Price Target Cut to $11.00/Share From $12.00 by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $11
Benzinga · 3d ago
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC) and Enlivex (ENLV)
TipRanks · 3d ago
BAUSCH HEALTH COMPANIES INC <BHC.N>: RBC CUTS TARGET PRICE TO $11 FROM $12
Reuters · 3d ago
Bausch Health Cos. Inc. Stock Falls Monday, Underperforms Market
Shares of Bausch Health Cos. Inc. Shed 3.02% to C$11.58 Monday. The company closed 3.85% below its 52-week high. The S&P/TSX Composite Index rose 0.30% to 21,871.96.
MarketWatch · 3d ago
Weekly Report: what happened at BHC last week (0415-0419)?
Weekly Report · 4d ago
Bausch Health Cos. Inc. Stock Rises Friday, Outperforms Market
Shares of Bausch Health Cos. Inc. Inched 0.84% higher to C$11.94 Friday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index rose 0.46% to 21,807.37.
MarketWatch · 6d ago
Bausch Health Cos. Inc. Stock Falls Thursday, Underperforms Market
Shares of Bausch Health Cos. Inc. Slipped 0.75% to C$11.84 on Thursday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index rose 0.24% to 21,708.44.
MarketWatch · 04/18 20:30
Bausch Health Cos. Inc. Stock Falls Wednesday, Underperforms Market
Shares of Bausch Health Cos. Inc. Shed 1.16% to C$11.93 on Wednesday. The company closed below its 52-week high of C$15.43. The S&P/TSX Composite Index rose 0.06% to 21,656.05.
MarketWatch · 04/17 20:30
Bausch Health Cos. Inc. Stock Rises Tuesday, Outperforms Market
Shares of Bausch Health Cos. Inc. BHC advanced 1.51% to C$12.07 Tuesday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index fell 0.45% to 21,642.87.
MarketWatch · 04/16 20:30
BUZZ-Medical device makers fall after J&J's medtech unit misses sales estimates
Shares of medical device makers fall between 1% and 3% after Johnson & Johnson's JNJ.N medical devices unit reports Q1 sales of $7.82 bln. Analysts point to weakness in JNJ's vision care products and surgical devices. Stryker, Zimmer Biomet and Medtronic among those down.
Reuters · 04/16 15:25
Bausch Health Cos. Inc. Stock Falls Monday, Underperforms Market
Shares of Bausch Health Cos. Inc. BHC dropped 1.49% to C$11.89 on Monday. The company closed short of its 52-week high of C$15.43. The S&P/TSX Composite Index fell 0.73% to 21,740.20.
MarketWatch · 04/15 20:30
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH)
TipRanks · 04/15 11:20
Weekly Report: what happened at BHC last week (0408-0412)?
Weekly Report · 04/15 09:13
More
Webull provides a variety of real-time BHC stock news. You can receive the latest news about Bausch Health Companies Inc through multiple platforms. This information may help you make smarter investment decisions.
About BHC
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.